Industry: Pharmaceuticals, Biotechnology
Oragenics, Inc. is a biopharmaceutical company with a pipeline of proprietary technologies. The Company has a number of products in discovery, preclinical and clinical development, with a concentration in two main therapeutic areas: infectious disease and oncology. Oragenics’ core pipeline includes products for use in the treatment of dental and periodontal infectious diseases, systemic bacterial infections and obesity. In the discovery stage are three platform technologies for identifying biomarkers of infection, cancer and autoimmune diseases and for the solid state synthesis of bioactive peptides including small molecule antibiotics. ( www.oragenics.com )
Oragenics , Inc.
13700 Progress Boulevard
Alachua, Florida 32615
USA
Tel: (386) 418-4018
Fax: (386) 418-1660